Medicx Fund Ltd. (LON:MXF) announced a dividend on Thursday, February 1st, Upcoming.Co.Uk reports. Investors of record on Thursday, February 15th will be paid a dividend of GBX 1.51 ($0.02) per share on Thursday, March 29th. This represents a dividend yield of 1.84%. The ex-dividend date is Thursday, February 15th. This is a positive change from Medicx Fund’s previous dividend of $1.50. The official announcement can be accessed at this link.
Shares of Medicx Fund (MXF) traded up GBX 81.18 ($1.14) during trading on Friday, hitting GBX 82 ($1.15). 404,857 shares of the company were exchanged, compared to its average volume of 387,921. Medicx Fund has a fifty-two week low of GBX 76.75 ($1.08) and a fifty-two week high of GBX 92.50 ($1.30). The firm has a market capitalization of $351.09 and a price-to-earnings ratio of 911.11.
Separately, Peel Hunt reaffirmed a “hold” rating and set a GBX 85 ($1.19) target price on shares of Medicx Fund in a report on Monday, November 20th.
ILLEGAL ACTIVITY WARNING: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/02/02/medicx-fund-ltd-mxf-announces-dividend-of-gbx-1-51.html.
About Medicx Fund
MedicX Fund Limited is a closed-ended investment company. The Company is a holding company. The Company’s investment objective is to achieve rising rental income and capital growth from the ownership of a portfolio of mainly modern, purpose built, primary healthcare properties. It invests in properties in accordance with the Company’s investment objective.
Receive News & Ratings for Medicx Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicx Fund and related companies with MarketBeat.com's FREE daily email newsletter.